---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-008817"
form_type: "8-K"
ticker: "DWTX"
cik: "0001818844"
company_name: "Dogwood Therapeutics, Inc."
filed_at: "2025-06-24T23:59:59+00:00"
generated_at: "2026-05-18T22:52:23.226744+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Shareholders approve 108,612-share increase to Dogwood equity incentive plan at annual meeting

## Summary
- Plan amendment raises shares reserved from 82,500 to 191,112; approved with 275,020 for, 6,482 against, 1,284 abstain.
- Seven directors elected: De La Rosa, Duncan, Keefer, Thomas, Toh, Whitley, Yu. No director changes announced.
- Ratification of Forvis Mazars as auditor for FY2025: 888,808 for, 31,671 against, 1,116 abstain.
- Annual meeting quorum: 921,595 shares (48.22% voting power).
- Amendment includes one-year minimum vesting for future grants, with limited exception for new hires.

## SEC filing metadata
- accession: 0001558370-25-008817
- form_type: 8-K
- ticker: DWTX
- cik: 0001818844
- company_name: Dogwood Therapeutics, Inc.
- filed_at: 2025-06-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818844/000155837025008817/0001558370-25-008817-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818844/000155837025008817/dwtx-20250618x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-008817
- JSON: https://secwatch.observer/filing/0001558370-25-008817.json
- Plain text: https://secwatch.observer/filing/0001558370-25-008817.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.